News

Filter by Category

Filter by Program

Filter by Date

October 28, 2020

C-Path and EATRIS To Collaborate on RDCA-DAP

C-Path has signed a Memorandum of Understanding with EATRIS, the European infrastructure for translational medicine, to accelerate

September 9, 2020

C-Path’s Patient-Reported Outcome (PRO) Consortium announced that it has been awarded a U.S. Food and Drug Administration (FDA)

September 3, 2020

C-Path’s Patient-Reported Outcome (PRO) Consortium announced today it has been awarded a U.S. Food and Drug Administratio

August 25, 2020

C-Path’s Crohn's Disease Biomarkers Pre-Consortium funded by The Helmsley Charitable Trust is proud to announce its...

August 21, 2020

Polycystic Kidney Disease (PKD) is an inherited disorder in which clusters of cysts develop in the kidneys. There are more than 20

August 14, 2020

C-Path’s ePRO Consortium is pleased to announce that “Demystifying Submissions of eCOA Documentation for Ethics

July 30, 2020

The Critical Path Institute and the Centre for Human Drug Research (CHDR) have joined forces to expand global collaborations for b

June 11, 2020

An online case reporting platform has been optimized for COVID-19 and will be the springboard for a new public-private drug

April 10, 2020

In collaboration with C-Path’s PRO Consortium, the ePRO Consortium has developed the presentation titled “Coronavirus D

March 26, 2020

In collaboration with the DIA Study Endpoints Community, C-Path’s ePRO Consortium is pleased to announce the open